| Rafael Lopez Monegro, MD | |
|
17a Beech Grove Road, Honesdale, PA 18431-1445 | |
| (570) 253-0800 | |
| (570) 253-0800 |
| Full Name | Rafael Lopez Monegro |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 17a Beech Grove Road, Honesdale, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699769778 | NPI | - | NPPES |
| 0012909800002 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD046535L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rafael Lopez Monegro, MD 17a Beech Grove Road, Honesdale, PA 18431-1445 Ph: (570) 253-0800 | Rafael Lopez Monegro, MD 17a Beech Grove Road, Honesdale, PA 18431-1445 Ph: (570) 253-0800 |
News Archive
Several studies have suggested there is a connection between organisms that cause gum disease, known scientifically as periodontal disease, and the development of heart disease, but few studies have tested this theory.
Identifying gaps in infection prevention practices may yield opportunities for improved patient safety, according to a survey published in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
ke microscopic inchworms, cancer cells slink away from tumors to travel and settle elsewhere in the body. Now, researchers at Weill Cornell Medical College report in today's online edition of the journal Nature that new anti-cancer agents break down the loping gait these cells use to migrate, stopping them in their tracks.
The National Association of Specialty Health Organizations today announced that nominations are being accepted for the first annual Most Influential in Specialty Health Award. This award will recognize leaders in specialty health who have played a major role in advancing the industry's mission to improve value, access and availability of high quality specialty health services.
Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in this process. They succeeded in reducing tumour growth in their experiments by blocking the phosphodiesterase PDE4.
› Verified 6 days ago